Annual report pursuant to Section 13 and 15(d)

ORGANIZATION AND PLAN OF BUSINESS OPERATIONS (Details)

v3.23.1
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS (Details)
 12 Months Ended
Jan. 12, 2022
USD ($)
item
Nov. 16, 2021
USD ($)
shares
Dec. 31, 2022
USD ($)
item
$ / shares
shares
Dec. 31, 2021
USD ($)
shares
Aug. 31, 2022
USD ($)
Jan. 31, 2022
USD ($)
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS            
Number of branded drugs in product portfolio | item 8   8      
Number of authorized generic prescription drugs | item     3      
Cash and cash equivalents     $ 32,003,000 $ 49,081,000    
Common stock par value | $ / shares     $ 0.0001      
Stock issued value       $ 30,615,000    
Borrowings     $ 27,948,000      
Prime rate            
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS            
Interest rate     1.73%      
Revolving line of credit            
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS            
Remaining borrowing capacity.     $ 2,900,000      
Interest rate     0.70%      
Revolving line of credit            
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS            
Maximum borrowing capacity $ 10,000,000.0          
Remaining borrowing capacity.     $ 7,100,000      
Term loan            
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS            
Borrowings         $ 5.0 $ 15.0
Term loan | Revolving line of credit            
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS            
Maximum borrowing capacity     $ 20.0      
Common Stock            
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS            
Common stock par value | $ / shares     $ 0.0001      
Number of shared issued for conversion of preferred stock | shares       2,231,346    
Number of shares issued for conversion of related part debt | shares       1,610,467    
Stock issued value     $ 150,000,000.0 $ 1,000    
Stock issued (in shares) | shares     4,900,000 3,520,000    
IPO            
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS            
Proceeds of initial public offering   $ 30,600,000        
Stock issued (in shares) | shares   3,520,000